Literature DB >> 29070986

Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy.

Matthias Dietzel1, Clemens Kaiser2, Katja Pinker3,4, Evelyn Wenkel1, Matthias Hammon1, Michael Uder1, Barbara Bennani Baiti4, Paola Clauser4, Rüdiger Schulz-Wendtland1, Pascal Baltzer4.   

Abstract

BACKGROUND: We aimed to investigate an automated semi-quantitative software as an imaging biomarker for the prediction of tissue response (TR) after completion of neoadjuvant chemotherapy (NAC).
METHODS: Breast magnetic resonance imaging (MRI) (1.5T, protocol according to international recommendations) of 67 patients with biopsy-proven invasive breast cancer were examined before and after NAC. After completion of NAC, histopathologic assessments of TR were classified according to the Chevallier grading system (CG1/4: full/non-responder; CG2/C3: partial responder). A commercially available fully automatic software (CADstream) extracted MRI parameters of tumor extension (tumor diameter/volume: TD/TV). Pre- versus post-NAC values were compared (ΔTV and ΔTD). Additionally, the software performed volumetric analyses of vascularization (VAV) after NAC. Accuracy of MRI parameters to predict TR were identified (cross-tabs, ROC, AUC, Kruskal-Wallis).
RESULTS: There were 37 (34.3%) CG1, 7 (6.5%) CG2, 53 (49.1%) CG3, and 11 (10.2%) CG4 lesions. The software reached area under the curve levels of 79.5% (CG1/complete response: ΔTD), 68.6% (CG2, CG3/partial response: VAV), and 88.8% to predict TR (CG4/non-response: ΔTV).
CONCLUSION: Semi-quantitative automated analysis of breast MRI data enabled the prediction of tissue response to NAC.

Entities:  

Keywords:  Breast MRI; Imaging biomarkers; Primary systemic chemotherapy; Therapy response

Year:  2017        PMID: 29070986      PMCID: PMC5649261          DOI: 10.1159/000480226

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  17 in total

1.  Clinical MR-mammography: are computer-assisted methods superior to visual or manual measurements for curve type analysis? A systematic approach.

Authors:  Pascal Andreas Thomas Baltzer; Christian Freiberg; Sebastian Beger; Tibor Vag; Matthias Dietzel; Aimee B Herzog; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Acad Radiol       Date:  2009-06-11       Impact factor: 3.173

2.  A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography.

Authors:  Pascal A T Baltzer; Matthias Dietzel; Werner A Kaiser
Journal:  Eur Radiol       Date:  2013-04-12       Impact factor: 5.315

3.  Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer.

Authors:  Pascal A T Baltzer; Tibor Vag; Matthias Dietzel; Sebastian Beger; Christian Freiberg; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

4.  Association between survival in patients with primary invasive breast cancer and computer aided MRI.

Authors:  Matthias Dietzel; Ramy Zoubi; Tibor Vag; Mieczyslaw Gajda; Ingo B Runnebaum; Werner A Kaiser; Pascal A Baltzer
Journal:  J Magn Reson Imaging       Date:  2012-09-25       Impact factor: 4.813

5.  Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.

Authors:  Kazuna Takeda; Shotaro Kanao; Tomohisa Okada; Masako Kataoka; Takayuki Ueno; Masakazu Toi; Hiroshi Ishiguro; Yoshiki Mikami; Kaori Togashi
Journal:  Eur J Radiol       Date:  2012-01-04       Impact factor: 3.528

6.  Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.

Authors:  H Preibsch; L Wanner; S D Bahrs; B M Wietek; K C Siegmann-Luz; E Oberlecher; M Hahn; A Staebler; K Nikolaou; B Wiesinger
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

7.  Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.

Authors:  Reiko Woodhams; Satoko Kakita; Hirofumi Hata; Keiichi Iwabuchi; Masaru Kuranami; Shiva Gautam; Hiroto Hatabu; Shinichi Kan; Carolyn Mountford
Journal:  Radiology       Date:  2010-02       Impact factor: 11.105

8.  Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection.

Authors:  H Kim; H H Kim; J S Park; H J Shin; J H Cha; E Y Chae; W J Choi
Journal:  Br J Radiol       Date:  2014-08-27       Impact factor: 3.039

9.  Breast MRI: guidelines from the European Society of Breast Imaging.

Authors:  R M Mann; C K Kuhl; K Kinkel; C Boetes
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

Review 10.  Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy.

Authors:  M L Marinovich; P Macaskill; L Irwig; F Sardanelli; G von Minckwitz; E Mamounas; M Brennan; S Ciatto; N Houssami
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

View more
  4 in total

1.  Is the whole larger than the sum of the parts? Integrated PET/MRI as a tool for response prediction.

Authors:  Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-26       Impact factor: 9.236

Review 2.  Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review.

Authors:  Weilin Xu; Xiu Chen; Fei Deng; Jian Zhang; Wei Zhang; Jinhai Tang
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

3.  Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves?

Authors:  Matthias Dietzel; Stephan Ellmann; Rüdiger Schulz-Wendtland; Paola Clauser; Evelyn Wenkel; Michael Uder; Pascal A T Baltzer
Journal:  Eur Radiol       Date:  2019-07-29       Impact factor: 5.315

4.  Dynamic Contrast-enhanced and Diffusion-weighted Magnetic Resonance Imaging for Response Evaluation After Single-Dose Ablative Neoadjuvant Partial Breast Irradiation.

Authors:  Jeanine E Vasmel; Maureen L Groot Koerkamp; Stefano Mandija; Wouter B Veldhuis; Maaike R Moman; Martijn Froeling; Bas H M van der Velden; Ramona K Charaghvandi; Celien P H Vreuls; Paul J van Diest; A M Gijs van Leeuwen; Joost van Gorp; Marielle E P Philippens; Bram van Asselen; Jan J W Lagendijk; Helena M Verkooijen; H J G Desirée van den Bongard; Antonetta C Houweling
Journal:  Adv Radiat Oncol       Date:  2021-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.